Opposition 91282389
OtherUSPTO
Opposition 91282389 at USPTO between Marvel Characters, Inc. and Xuegang Li, over the mark MARVENGER, filed Dec 19, 2022. Status in the office record: other.
- Status
- Other
- Result
- Other
- Filed
- Dec 19, 2022
- Marks involved
- 24
Parties
Who is involved
The parties as named in the office record.
Respondent
Xuegang Li
Timeline
How the case has moved
Dates from the USPTO record and the MARVENGER filing.
MARVENGER filed
Application 97163236 filed at the USPTO.Opposition filed
Marvel Characters, Inc. started opposition 91282389 at USPTO against MARVENGER.
Marks
Marks involved
1 contested mark, 23 marks the challenger relies on.
| Mark | Role | Application | Office |
|---|---|---|---|
| MARVENGER | Contested | 97163236 | USPTO |
| MARVEL | Relied on | 72277923 | USPTO |
| THE AVENGERS | Relied on | 72278015 | USPTO |
| MARVEL | Relied on | 74214396 | USPTO |
| MARVEL | Relied on | 74214398 | USPTO |
| MARVEL | Relied on | 74214399 | USPTO |
| AVENGERS | Relied on | 75055468 | USPTO |
| MARVEL | Relied on | 77557580 | USPTO |
| MARVEL | Relied on | 77557582 | USPTO |
| AVENGERS | Relied on | 78402866 | USPTO |
| AVENGERS | Relied on | 85159382 | USPTO |
| MARVEL | Relied on | 85319257 | USPTO |
+12 more marks in this case
API
Get this data via the API
Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.
GET/v1/proceedings/{id}Parties, dates, outcome and every mark in the case
GET/v1/proceedings?trademark_id={trademark_id}Every proceeding on a mark
GET /v1/proceedings/{id}
ID=prc_8b150eff-641c-4c87-bd69-0f895c0a9edb
curl https://api.signa.so/v1/proceedings/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"Response
{
"id": "prc_8b150eff-641c-4c87-bd69-0f895c0a9edb",
"object": "proceeding",
"proceeding_type": "opposition",
"proceeding_number": "91282389",
"status": "other",
"office_code": "US",
"filed_date": "2022-12-19",
"parties": [
{
"name": "Marvel Characters, Inc.",
"role": "opponent"
},
{
"name": "Xuegang Li",
"role": "respondent"
}
]
}